These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 35447408)
1. Exploration of naphthoquinone analogs in targeting the TCF-DNA interaction to inhibit the Wnt/β-catenin signaling pathway. Morris A; Hoyle R; Pagare PP; Uz Zaman S; Ma Z; Li J; Zhang Y Bioorg Chem; 2022 Jul; 124():105812. PubMed ID: 35447408 [TBL] [Abstract][Full Text] [Related]
2. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis. Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932 [TBL] [Abstract][Full Text] [Related]
3. The leukemia-associated Mllt10/Af10-Dot1l are Tcf4/β-catenin coactivators essential for intestinal homeostasis. Mahmoudi T; Boj SF; Hatzis P; Li VS; Taouatas N; Vries RG; Teunissen H; Begthel H; Korving J; Mohammed S; Heck AJ; Clevers H PLoS Biol; 2010 Nov; 8(11):e1000539. PubMed ID: 21103407 [TBL] [Abstract][Full Text] [Related]
4. CREPT/RPRD1B, a recently identified novel protein highly expressed in tumors, enhances the β-catenin·TCF4 transcriptional activity in response to Wnt signaling. Zhang Y; Liu C; Duan X; Ren F; Li S; Jin Z; Wang Y; Feng Y; Liu Z; Chang Z J Biol Chem; 2014 Aug; 289(33):22589-22599. PubMed ID: 24982424 [TBL] [Abstract][Full Text] [Related]
5. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling. Han P; Li JW; Zhang BM; Lv JC; Li YM; Gu XY; Yu ZW; Jia YH; Bai XF; Li L; Liu YL; Cui BB Mol Cancer; 2017 Jan; 16(1):9. PubMed ID: 28086904 [TBL] [Abstract][Full Text] [Related]
6. Tumor-suppressive miR-145 co-repressed by TCF4-β-catenin and PRC2 complexes forms double-negative regulation loops with its negative regulators in colorectal cancer. Wang W; Xiao X; Chen X; Huo Y; Xi WJ; Lin ZF; Zhang D; Li YF; Yang F; Wen WH; Yang AG; Wang T Int J Cancer; 2018 Jan; 142(2):308-321. PubMed ID: 28921929 [TBL] [Abstract][Full Text] [Related]
7. KSHV vPK inhibits Wnt signaling via preventing interactions between β-catenin and TCF4. Cha S; Kang MS; Seo T Biochem Biophys Res Commun; 2018 Feb; 497(1):381-387. PubMed ID: 29432739 [TBL] [Abstract][Full Text] [Related]
8. Human telomerase reverse transcriptase (hTERT) is a novel target of the Wnt/β-catenin pathway in human cancer. Zhang Y; Toh L; Lau P; Wang X J Biol Chem; 2012 Sep; 287(39):32494-511. PubMed ID: 22854964 [TBL] [Abstract][Full Text] [Related]
9. The anthelmintic niclosamide inhibits colorectal cancer cell lines via modulation of the canonical and noncanonical Wnt signaling pathway. Monin MB; Krause P; Stelling R; Bocuk D; Niebert S; Klemm F; Pukrop T; Koenig S J Surg Res; 2016 Jun; 203(1):193-205. PubMed ID: 27338550 [TBL] [Abstract][Full Text] [Related]
10. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells. Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031 [TBL] [Abstract][Full Text] [Related]
12. The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway. Chen HJ; Hsu LS; Shia YT; Lin MW; Lin CM Biochem Pharmacol; 2012 Nov; 84(9):1143-53. PubMed ID: 22935447 [TBL] [Abstract][Full Text] [Related]
13. Chlorquinaldol targets the β-catenin and T-cell factor 4 complex and exerts anti-colorectal cancer activity. Wang L; Deng K; Gong L; Zhou L; Sayed S; Li H; Sun Q; Su Z; Wang Z; Liu S; Zhu H; Song J; Lu D Pharmacol Res; 2020 Sep; 159():104955. PubMed ID: 32485279 [TBL] [Abstract][Full Text] [Related]
14. MiR-452 promotes an aggressive colorectal cancer phenotype by regulating a Wnt/β-catenin positive feedback loop. Li T; Jian X; He H; Lai Q; Li X; Deng D; Liu T; Zhu J; Jiao H; Ye Y; Wang S; Yang M; Zheng L; Zhou W; Ding Y J Exp Clin Cancer Res; 2018 Sep; 37(1):238. PubMed ID: 30253791 [TBL] [Abstract][Full Text] [Related]
15. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer. Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543 [TBL] [Abstract][Full Text] [Related]
17. β-Catenin/TCF4 Complex-Mediated Induction of the Aono S; Hatanaka A; Hatanaka A; Gao Y; Hippo Y; Taketo MM; Waku T; Kobayashi A Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31288376 [TBL] [Abstract][Full Text] [Related]
18. Context-dependent activation of Wnt signaling by tumor suppressor RUNX3 in gastric cancer cells. Ju X; Ishikawa TO; Naka K; Ito K; Ito Y; Oshima M Cancer Sci; 2014 Apr; 105(4):418-24. PubMed ID: 24447505 [TBL] [Abstract][Full Text] [Related]
19. Investigation of 3-aryl-pyrimido[5,4-e][1,2,4]triazine-5,7-diones as small molecule antagonists of β-catenin/TCF transcription. Zeller J; Turbiak AJ; Powelson IA; Lee S; Sun D; Showalter HD; Fearon ER Bioorg Med Chem Lett; 2013 Nov; 23(21):5814-20. PubMed ID: 24060489 [TBL] [Abstract][Full Text] [Related]
20. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors. Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]